Generated July 16, 2026 at 8:33 PM ET
· Covers July 16 trading day
· 10 of 177 ready 8-Ks selected
· AI-assisted overview
The day's filings featured several high-materiality M&A events: Eli Lilly agreed to acquire AtaiBeckley for $6.75 per share plus contingent value rights, and Baker Hughes closed its $210-per-share acquisition of Chart Industries, targeting $325 million in cost synergies. Arbutus Biopharma received $178 million from a Moderna settlement and filed patent lawsuits against Pfizer/BioNTech. Leadership changes included BioRestorative's CEO and CFO resigning amid a disputed change-in-control claim, and SpringBig transferring assets to LS Round II, LLC while eliminating $12.5 million in debt and appointing a new CEO. Regulatory actions saw Cycurion and Our Bond receive Nasdaq delisting notices for bid price non-compliance, while SRx Health regained NYSE American listing compliance. Coca-Cola reported a ransomware attack at its fairlife subsidiary, temporarily suspending US production.
BRTX
BioRestorative Therapies, Inc.
leadership
negative
materiality 0.85
July 16, 2026, 5:30 PM ET
BioRestorative CEO and CFO resign; board appoints new CEO, investigates employment agreements
- CEO Lance Alstodt and CFO Robert Kristal resigned July 13, 2026, claiming 'Good Reason' under alleged Change in Control; seek ~$2.85M aggregate severance plus equity acceleration.
- Board appointed director Katharyn Field as CEO, President, and interim CFO; she also serves as CEO of iSpecimen (ISPC).
- Board elected Esha Randhawa and Steven Brown as new directors; committees reconstituted with new chairs.
regulatory
negative
materiality 0.80
July 16, 2026, 4:52 PM ET
Cycurion receives Nasdaq delisting notice for bid price non-compliance; plans appeal
- Received Nasdaq delisting letter on July 10, 2026 due to bid price below $1.00 for 31 consecutive days (May 26-Jul 9, 2026).
- Ineligible for 180-day compliance period due to 1-for-30 reverse stock split on Oct 27, 2025; trading suspension set for Jul 21 if no hearing.
- Plans to request hearing before Jul 17 deadline; hearing will stay suspension and trading continues during appeal.
M&A
positive
materiality 0.90
July 16, 2026, 8:54 AM ET
Baker Hughes closes $210/share acquisition of Chart Industries; targets $325M cost synergies
- Acquisition closed at $210.00 per share in cash; Chart becomes third operating segment.
- Targets $325 million in annualized cost synergies within three years after close.
- Chart reported $4.3 billion revenue for FY2025; serves customers in 50+ countries.
ABUS
Arbutus Biopharma Corp
litigation
positive
materiality 0.90
July 16, 2026, 7:31 AM ET
Arbutus receives $178M from Moderna settlement, files patent suits against Pfizer/BioNTech, plans $230M share repurchase
- Received approximately $178M from Moderna as its share of noncontingent settlement payment on July 8, 2026.
- Filed three international patent infringement lawsuits against Pfizer/BioNTech in Canada and UPC seeking injunctions and damages.
- Entered termination agreement with Genevant for RSV agreement, with Genevant paying $1.0M termination fee.
M&A
positive
materiality 1.00
July 16, 2026, 7:27 AM ET
AtaiBeckley to be acquired by Eli Lilly for $6.75/share plus CVRs up to $2.50/share
- Merger consideration: $6.75 per share cash plus one CVR per share with potential milestone payments up to $2.50 per share.
- CVR milestones: $1.00 for VLS-01 Phase 3 start, $0.50 for BPL-003 US approval/DEA rescheduling, $1.00 for VLS-01 US approval/DEA rescheduling.
- Termination fee of $104.3M payable by AtaiBeckley under certain conditions; no-shop with fiduciary out.
regulatory
negative
materiality 0.75
July 16, 2026, 5:10 PM ET
Our Bond receives Nasdaq delisting notice for bid price, market value non-compliance
- Received Nasdaq notification letters on July 14, 2026 for three listing deficiencies.
- Bid price below $1.00 for 30 consecutive days; market value of publicly held shares below $15M.
- Market value of listed securities below $50M; 180-day cure period until January 11, 2027.
GTLS
CHART INDUSTRIES INC
M&A
neutral
materiality 1.00
July 16, 2026, 9:02 AM ET
Baker Hughes completes acquisition of Chart Industries for $210 per share in cash
- Merger closed July 16, 2026; Chart shareholders receive $210.00 per share in cash.
- Baker Hughes funded via $6.5B and €3.0B senior notes, term loans, and cash on hand.
- Chart's $1.457B Secured Notes and $510M Unsecured Notes redeemed; credit agreement prepaid.
SBIG
SpringBig Holdings, Inc.
debt
negative
materiality 0.90
July 16, 2026, 4:53 PM ET
SpringBig Holdings transfers assets to LS Round II, LLC, releases $12.5M debt, appoints new CEO
- Transferred all equity of subsidiary SpringBig, Inc. to LS Round II, LLC under Reorganization Agreement dated July 13, 2026.
- Eliminated approximately $12.5 million in principal and accrued interest on Senior Secured Convertible and Term Promissory Notes.
- Appointed Andrew Jay Glashow as CEO and Class I director effective July 10, 2026, with annual salary of $125,000.
cyber
negative
materiality 0.70
July 16, 2026, 4:20 PM ET
Coca-Cola reports ransomware attack at fairlife subsidiary; US production suspended
- fairlife, a Coca-Cola-owned dairy company, experienced unauthorized access and a ransomware event on its systems.
- US production operations at fairlife are temporarily suspended; Canada operations are not impacted.
- Product quality and safety have not been affected by the incident.
SRXH
SRx Health Solutions, Inc.
regulatory
positive
materiality 0.60
July 16, 2026, 10:42 AM ET
SRX Global regains NYSE American listing compliance; resolves Section 1003(a)(i) and (ii) deficiency
- Received NYSE American notice on July 15, 2026 confirming compliance with continued listing standards.
- Resolved deficiency under Section 1003(a)(i) and (ii) of the NYSE American Company Guide, originally cited in October 2025.
- Compliance indicator ".BC" will be removed; company removed from noncompliant issuer list.